Regulation of buccal mucosal calcium channel activity by salivary mucins. 1993

B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
Research Center, New Jersey Dental School, University of Medicine and Dentistry of New Jersey, Newark 07103-2400.

1. The effect salivary mucins on the activity of calcium channel isolated from buccal mucosal cell membranes was investigated. The uptake of 45Ca2+ while only moderately (15%) affected by the intact low and high molecular weight mucin forms, was significantly inhibited, by the acidic low and high molecular weight salivary mucins which evoked 64 and 60% inhibition, respectively. 2. The inhibitory effect of salivary mucins was associated with the sialic acid and sulfate ester groups of the carbohydrate chains, as the removal of either group caused partial loss in the glycoproteins inhibition, and the complete loss in the inhibitory effect occurred following desialylation and desulfation. 3. The channel in the presence of epidermal growth factor (EGF) and ATP responded by an increase in tyrosine phosphorylation of 55 and 170 kDa proteins, and the phosphorylated channels showed a 46% increase in 45Ca2+ uptake. The phosphorylation and the calcium uptake were susceptible to inhibition by a specific tyrosine kinase inhibitor, genistein. 4. The binding of EGF to calcium channel receptor protein was inhibited by the low and high molecular weight acidic mucins, causing 41.2 and 36.1% reduction, respectively. This reduction in binding was dependent upon the presence of sulfate ester and sialic acid groups, as evidenced by the loss of the glycoproteins' inhibitory capacity following removal of these groups. 5. The results for the first time demonstrate that salivary mucins actively participate in the modulation of the EGF-controlled buccal mucosal calcium channel activity expression, a process of importance to the preservation of oral tissue integrity.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009061 Mouth Mucosa Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations. Buccal Mucosa,Oral Mucosa,Mucosa, Mouth,Mucosa, Oral
D009077 Mucins High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface. Mucin
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002610 Cheek The part of the face that is below the eye and to the side of the nose and mouth. Bucca,Buccas,Cheeks
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012471 Salivary Proteins and Peptides Proteins and peptides found in SALIVA and the SALIVARY GLANDS. Some salivary proteins such as ALPHA-AMYLASES are enzymes, but their composition varies in different individuals. Salivary Gland Protein,Salivary Gland Proteins,Salivary Peptide,Salivary Protein,Salivary Proteins,Salivary Peptides,Gland Protein, Salivary,Peptide, Salivary,Protein, Salivary,Protein, Salivary Gland
D015220 Calcium Channels Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue. Ion Channels, Calcium,Receptors, Calcium Channel Blocker,Voltage-Dependent Calcium Channel,Calcium Channel,Calcium Channel Antagonist Receptor,Calcium Channel Antagonist Receptors,Calcium Channel Blocker Receptor,Calcium Channel Blocker Receptors,Ion Channel, Calcium,Receptors, Calcium Channel Antagonist,VDCC,Voltage-Dependent Calcium Channels,Calcium Channel, Voltage-Dependent,Calcium Channels, Voltage-Dependent,Calcium Ion Channel,Calcium Ion Channels,Channel, Voltage-Dependent Calcium,Channels, Voltage-Dependent Calcium,Voltage Dependent Calcium Channel,Voltage Dependent Calcium Channels

Related Publications

B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
January 1993, Biochemistry and molecular biology international,
B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
March 1994, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
June 2014, Microscopy research and technique,
B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
July 1996, General pharmacology,
B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
December 1992, Biochemistry international,
B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
June 1993, The International journal of biochemistry,
B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
July 1998, The Journal of biological chemistry,
B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
December 2020, Head and neck pathology,
B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
June 1993, The American journal of gastroenterology,
B L Slomiany, and Z Fekete, and V L Murty, and M Grabska, and J Piotrowski, and F Yotsumoto, and A Czajkowski, and A Slomiany
October 1990, FEMS microbiology immunology,
Copied contents to your clipboard!